Notably, the OS of patients expressing high BCYRN1 levels was significantly reduced relative to that of patients expressing low levels of BCYRN1 (Figure 1(b)), and analyses of the Kaplan-Meier plotter data conducted using the GEPIA server demonstrated that increased BCYRN1 expression was indeed linked to poorer HCC patient OS (Figure 1(c)). Here, BCYRN1 is linked to hepatocellular carcinoma.